SFA
TARA icon

Semmax Financial Advisors’s Protara Therapeutics TARA Stock Holding History

Semmax Financial Advisors’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$4.92K Hold
1,572
– – ﹤0.01% 297
2025
Q1 		$5.09K Hold
1,572
– – ﹤0.01% 273
2024
Q4 		$6.87K Hold
1,572
– – ﹤0.01% 245
2024
Q3 		$4.06K Buy
+1,572
New +$3.23K ﹤0.01% 260

Other funds holding TARA

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
CCM
Catalio Capital Management New York $479M AUM 140.7% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Semmax Financial Advisors's TARA Position: Q2 2025 in Review

Semmax Financial Advisors held its Protara Therapeutics (TARA) position steady in Q2 2025 at 1,572 shares worth $4.92K. The position accounts for ﹤0.01% of the portfolio, ranked #297.

Semmax Financial Advisors first reported a position in TARA in Q3 2024 and has held it in 4 quarters since. The position peaked at $6.87K in Q4 2024. 76 funds tracked by Wall St. Rank hold TARA as of Q2 2025.

  • Semmax Financial Advisors held 1,572 shares of Protara Therapeutics worth $4.92K as of Q2 2025.
  • Semmax Financial Advisors left its Protara Therapeutics share count unchanged in Q2 2025.
  • Protara Therapeutics made up ﹤0.01% of Semmax Financial Advisors's portfolio in Q2 2025, its #297 holding.
  • Semmax Financial Advisors first reported a position in Protara Therapeutics in Q3 2024 and has held it in 4 quarters since.
  • Semmax Financial Advisors's Protara Therapeutics position peaked at $6.87K in Q4 2024.
  • 76 funds tracked by Wall St. Rank held Protara Therapeutics as of Q2 2025.

Based on Semmax Financial Advisors's 13F filing for Q2 2025, filed 15 Aug 2025.